PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
24.47
-0.61 (-2.41%)
Mar 27, 2026, 9:52 AM EDT - Market open
PROCEPT BioRobotics Revenue
In the year 2025, PROCEPT BioRobotics had annual revenue of $308.05M with 37.22% growth. PROCEPT BioRobotics had revenue of $76.38M in the quarter ending December 31, 2025, with 11.94% growth.
Revenue (ttm)
$308.05M
Revenue Growth
+37.22%
P/S Ratio
4.59
Revenue / Employee
$346,908
Employees
888
Market Cap
1.38B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 308.05M | 83.56M | 37.22% |
| Dec 31, 2024 | 224.50M | 88.31M | 64.84% |
| Dec 31, 2023 | 136.19M | 61.18M | 81.55% |
| Dec 31, 2022 | 75.01M | 40.54M | 117.60% |
| Dec 31, 2021 | 34.47M | 26.76M | 346.72% |
| Dec 31, 2020 | 7.72M | 1.55M | 25.09% |
| Dec 31, 2019 | 6.17M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AdaptHealth | 3.24B |
| Enovis | 2.25B |
| CONMED | 1.37B |
| Tandem Diabetes Care | 1.01B |
| Inspire Medical Systems | 911.98M |
| Alphatec Holdings | 764.16M |
| NovoCure | 655.35M |
| UFP Technologies | 602.80M |
PRCT News
- 4 days ago - EAU Guidelines Upgrade Aquablation® Therapy to Strong Surgical Recommendation for BPH - GlobeNewsWire
- 15 days ago - PROCEPT BioRobotics® Announces International Launch of the HYDROS® Robotic System, Expanding Global Access to AI-Enabled Aquablation® Therapy - GlobeNewsWire
- 18 days ago - PRCT Investors Have Opportunity to Join PROCEPT BioRobotics Corporation Fraud Investigation with the Schall Law Firm - Business Wire
- 20 days ago - PROCEPT BioRobotics Corporation (PRCT) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 22 days ago - PROCEPT BioRobotics Corporation (PRCT) Analyst/Investor Day Transcript - Seeking Alpha
- 4 weeks ago - Ademi LLP Investigates Claims of Securities Fraud against PROCEPT BioRobotics Corporation - PRNewsWire
- 4 weeks ago - PROCEPT BioRobotics Corporation (PRCT) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - PROCEPT BioRobotics® Hosts 2026 Investor Day to Detail Multi-year Financial Outlook and Strategic Plan for Long-Term Growth - GlobeNewsWire